2-127421438-G-A
Variant summary
Our verdict is Likely pathogenic. The variant received 9 ACMG points: 9P and 0B. PP2PP5_Very_Strong
The NM_000312.4(PROC):c.226G>A(p.Val76Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000134 in 1,613,810 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000312.4 missense
Scores
Clinical Significance
Conservation
Publications
- hereditary thrombophilia due to congenital protein C deficiencyInheritance: AD, SD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- thrombophilia due to protein C deficiency, autosomal dominantInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics
- thrombophilia due to protein C deficiency, autosomal recessiveInheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 9 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000312.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PROC | NM_000312.4 | MANE Select | c.226G>A | p.Val76Met | missense | Exon 3 of 9 | NP_000303.1 | ||
| PROC | NM_001375607.1 | c.310G>A | p.Val104Met | missense | Exon 3 of 8 | NP_001362536.1 | |||
| PROC | NM_001375602.1 | c.409G>A | p.Val137Met | missense | Exon 3 of 9 | NP_001362531.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PROC | ENST00000234071.8 | TSL:1 MANE Select | c.226G>A | p.Val76Met | missense | Exon 3 of 9 | ENSP00000234071.4 | ||
| PROC | ENST00000409048.1 | TSL:5 | c.226G>A | p.Val76Met | missense | Exon 2 of 7 | ENSP00000386679.1 | ||
| PROC | ENST00000442644.5 | TSL:3 | c.226G>A | p.Val76Met | missense | Exon 3 of 7 | ENSP00000411241.1 |
Frequencies
GnomAD3 genomes AF: 0.0000788 AC: 12AN: 152254Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000518 AC: 13AN: 250918 AF XY: 0.0000589 show subpopulations
GnomAD4 exome AF: 0.000140 AC: 205AN: 1461556Hom.: 0 Cov.: 32 AF XY: 0.000120 AC XY: 87AN XY: 727048 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000788 AC: 12AN: 152254Hom.: 0 Cov.: 33 AF XY: 0.0000672 AC XY: 5AN XY: 74382 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Abnormal thrombosis Pathogenic:1
Thrombophilia due to protein C deficiency, autosomal recessive Pathogenic:1
Cerebral palsy Pathogenic:1
PROC-related disorder Pathogenic:1
The PROC c.226G>A variant is predicted to result in the amino acid substitution p.Val76Met. This variant is also described with legacy nomenclature as p.Val34Met, and was reported along with a second potentially causative variant in three individuals from a single family with protein C deficiency (Long. 1992. PubMed ID: 1347706). This variant has also been reported in the heterozygous state in two patients with an unspecified bleeding, thrombotic, or platelet disorder (Wu. 2013. PubMed ID: 24051141; Table S3, Downes. 2019. PubMed ID: 31064749). In vitro functional studies found this variant results in decreased protein synthesis and reduced activation (Wu. 2013. PubMed ID: 24051141).This variant is reported in 0.010% of alleles in individuals of European (Non-Finnish) descent in gnomAD. This variant is interpreted as likely pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at